2010
DOI: 10.1200/jco.2010.28.15_suppl.7552
|View full text |Cite
|
Sign up to set email alerts
|

The association between PTEN expression and survival in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with erlotinib.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2011
2011
2011
2011

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…This has been particularly helpful when studying patients treated with oral therapeutics, which can be difficult in the paper chart setting. 8,9 Because oral chemotherapy agents have been ordered through the Epic EHR for many years, reports can be generated that include patients treated with a particular agent over a specified time period with pertinent demographic data and laboratory results, including tumor histology. Several of the research groups within the cancer center have also traditionally used prospective databases that are on other platforms, such as Microsoft Access.…”
Section: Researchmentioning
confidence: 99%
“…This has been particularly helpful when studying patients treated with oral therapeutics, which can be difficult in the paper chart setting. 8,9 Because oral chemotherapy agents have been ordered through the Epic EHR for many years, reports can be generated that include patients treated with a particular agent over a specified time period with pertinent demographic data and laboratory results, including tumor histology. Several of the research groups within the cancer center have also traditionally used prospective databases that are on other platforms, such as Microsoft Access.…”
Section: Researchmentioning
confidence: 99%